Ibritumomab Intravenous and In-111 DTPA
Determining the interaction of Ibritumomab Intravenous and In-111 DTPA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Inamrinone
- Ibritumomab Intravenous-Inapsine
- Ibritumomab Intravenous-Inatal Advance
- Ibritumomab Intravenous-Inatal Ultra
- Ibritumomab Intravenous-Inbrija
- Ibritumomab Intravenous-Incassia
- In-111 DTPA-Ibritumomab Tiuxetan
- In-111 DTPA-Ibrutinib
- In-111 DTPA-Ibrutinib Capsules
- In-111 DTPA-Ibrutinib Tablets
- In-111 DTPA-Ibu
- In-111 DTPA-IBU Tablets